Healix Executive and Leadership Team

Brit Pim, the Chief Executive Officer at Healix, directs the overarching strategic vision for physician office-based infusion services. By aligning clinical excellence with operational efficiency, the Chief Executive Officer ensures that outpatient settings maintain the highest standards of patient safety and regulatory compliance. Pim manages the executive team to drive growth across North American markets, focusing on expanding access to specialized infusion therapies. This leadership role involves constant collaboration with the Board to refine service models that enhance physician peace of mind. Through rigorous oversight of clinical outcomes, the Chief Executive Officer maintains the company's reputation as a national leader in the infusion space. Brit Pim actively monitors industry trends to adapt service delivery, ensuring that the organization remains at the forefront of outpatient care innovation while supporting long-term financial stability and operational excellence.

Becky White-Steensma, the Chief Executive Officer & Founder at Healix, architects the foundational mission of providing superior infusion services within physician offices. The Chief Executive Officer & Founder drives the long-term vision for patient-centric care, ensuring that every clinical protocol supports optimal health outcomes. By fostering a culture of compliance and quality, White-Steensma guides the organization through complex regulatory landscapes in the healthcare sector. This leadership role involves setting the strategic direction for national expansion, ensuring that physician partners receive unparalleled support for infusion delivery. Through consistent focus on service quality, the Chief Executive Officer & Founder secures the company's market position as a trusted partner for medical practices. Becky White-Steensma oversees the integration of new clinical capabilities, maintaining a steadfast commitment to the original goal of improving patient comfort and physician peace of mind across all operational regions.

Melisa Norton, the Chief Financial Officer at Healix, manages the fiscal health and capital allocation strategies necessary for sustaining national infusion service operations. The Chief Financial Officer directs financial planning, budgeting, and revenue cycle management to ensure the company maintains robust growth trajectories. By analyzing market data and operational costs, Norton optimizes resource distribution across all outpatient infusion sites. This leadership role involves close coordination with the executive team to evaluate investment opportunities in new clinical technologies and service expansions. Through meticulous financial reporting and risk assessment, the Chief Financial Officer provides the transparency required for strategic decision-making at the board level. Melisa Norton ensures that fiscal policies align with the company's mission of delivering high-quality patient care, ultimately securing the financial foundation that allows the organization to scale its specialized services effectively throughout the United States.

Casey Lucas, the Chief Operating Officer & Executive VP, Sales at Healix, executes the daily operational workflows and sales strategies that drive the adoption of infusion services. The Chief Operating Officer & Executive VP, Sales oversees the expansion of the sales force, targeting new physician partnerships to increase the company's national footprint. By streamlining operational processes, Lucas ensures that infusion sites function with maximum efficiency and clinical compliance. This leadership role involves managing the interface between sales growth and operational capacity, ensuring that service delivery meets the high standards expected by medical practices. Through the implementation of scalable business models, the Chief Operating Officer & Executive VP, Sales supports the company's mission of providing accessible outpatient care. Casey Lucas directs the sales team to identify market opportunities, ensuring that the organization consistently meets its growth targets while maintaining superior patient outcomes.

Mark Winters, the Partner, Executive Board Member, President at Healix, directs high-level governance and strategic initiatives to ensure the company's long-term success. The Partner, Executive Board Member, President oversees the alignment of corporate objectives with the needs of physician partners, focusing on sustainable growth and market leadership. By participating in board-level decision-making, Winters shapes the policies that govern clinical standards and service expansion. This leadership role involves fostering relationships with key stakeholders to maintain the company's reputation for excellence in outpatient infusion services. Through the oversight of organizational performance, the Partner, Executive Board Member, President ensures that the company remains competitive in the evolving healthcare landscape. Mark Winters actively contributes to the strategic planning process, ensuring that the organization continues to provide physician office-based infusion services that prioritize patient outcomes and clinical compliance across all operational regions.

Blake Griese, the General Counsel & Head of Pharmacy at Healix, directs the legal framework and pharmaceutical operations essential for safe infusion service delivery. The General Counsel & Head of Pharmacy manages regulatory compliance, ensuring that all pharmacy practices adhere to strict national standards for patient safety and drug handling. By overseeing the procurement and distribution of specialized medications, Griese maintains the integrity of the supply chain across all outpatient settings. This leadership role involves navigating complex healthcare laws to protect the company's interests while facilitating seamless clinical operations. Through the integration of legal oversight and pharmacy management, the General Counsel & Head of Pharmacy mitigates risk and supports the company's commitment to clinical excellence. Blake Griese ensures that all pharmacy protocols align with the broader mission of providing physician office-based infusion services that prioritize patient health and regulatory adherence.

Tom Reinckens, the Chief Information & Procurement Officer at Healix, architects the digital infrastructure and supply chain systems that support national infusion operations. The Chief Information & Procurement Officer directs the implementation of health information technology to ensure secure data management and efficient clinical workflows. By managing procurement strategies, Reinckens optimizes the acquisition of medical supplies and equipment, ensuring that infusion sites remain fully stocked and operational. This leadership role involves coordinating with clinical and operational teams to integrate technology solutions that enhance patient care and physician efficiency. Through the strategic management of information systems and vendor relationships, the Chief Information & Procurement Officer drives operational productivity across the organization. Tom Reinckens ensures that the company's technological and supply chain capabilities remain robust, supporting the overall mission of delivering high-quality, compliant infusion services in outpatient settings.